Financial Survey: PACS Group (PACS) & Its Competitors

PACS Group (NYSE:PACS) is one of 93 public companies in the “Medical Services” industry, but how does it contrast to its competitors? We will compare PACS Group to similar businesses based on the strength of its profitability, institutional ownership, analyst recommendations, dividends, earnings, valuation and risk.

Insider and Institutional Ownership

58.1% of shares of all “Medical Services” companies are held by institutional investors. 13.3% of shares of all “Medical Services” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Volatility and Risk

PACS Group has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500. Comparatively, PACS Group’s competitors have a beta of 1.53, indicating that their average stock price is 53% more volatile than the S&P 500.

Profitability

This table compares PACS Group and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PACS Group	N/A	N/A	N/A
PACS Group Competitors	-901.88%	-59.99%	-13.64%

Earnings & Valuation

This table compares PACS Group and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
PACS Group	$3.11 billion	$112.87 million	50.85
PACS Group Competitors	$9.90 billion	$239.88 million	12.43

PACS Group’s competitors have higher revenue and earnings than PACS Group. PACS Group is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a summary of recent ratings for PACS Group and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	1	1	2	0	2.25
PACS Group Competitors	625	2493	5123	184	2.58

PACS Group currently has a consensus price target of $24.67, indicating a potential upside of 56.46%. As a group, “Medical Services” companies have a potential upside of 368.66%. Given PACS Group’s competitors stronger consensus rating and higher possible upside, analysts plainly believe PACS Group has less favorable growth aspects than its competitors.

Summary

PACS Group competitors beat PACS Group on 9 of the 13 factors compared.

PACS Group Company Profile

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.